154 related articles for article (PubMed ID: 2145239)
1. Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients.
Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
Int J Cardiol; 1990 Jul; 28 Suppl 1():S7-11. PubMed ID: 2145239
[TBL] [Abstract][Full Text] [Related]
2. Comparison of dobutamine and enoximone for low output states following cardiac surgery.
Orellano L; Darwisch M; Dieterich HA; Köllner V
Int J Cardiol; 1990 Jul; 28 Suppl 1():S13-9. PubMed ID: 2145233
[TBL] [Abstract][Full Text] [Related]
3. Addition of enoximone to adrenergic agents in the management of severe heart failure.
Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
Crit Care Med; 1992 Aug; 20(8):1102-6. PubMed ID: 1386567
[TBL] [Abstract][Full Text] [Related]
4. The role of enoximone in the treatment of cardiogenic shock.
Vincent JL; Léon M; Berré J
Cardiology; 1990; 77 Suppl 3():21-6; discussion 27-33. PubMed ID: 2176130
[TBL] [Abstract][Full Text] [Related]
5. Enoximone improves selection of candidates for urgent cardiac transplantation.
Loisance D; Benvenuti C; Dubois Randé JL; Deleuze P; Castaigne A; Cachera JP
Int J Cardiol; 1990 Jul; 28 Suppl 1():S23-7. PubMed ID: 2145234
[TBL] [Abstract][Full Text] [Related]
6. Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension.
Hachenberg T; Möllhoff T; Holst D; Hammel D; Brüssel T
J Cardiothorac Vasc Anesth; 1997 Jun; 11(4):453-7. PubMed ID: 9187994
[TBL] [Abstract][Full Text] [Related]
7. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
[TBL] [Abstract][Full Text] [Related]
8. Administration of enoximone in cardiogenic shock.
Vincent JL; Carlier E; Berré J; Armistead CW; Kahn RJ; Coussaert E; Cantraine F
Am J Cardiol; 1988 Sep; 62(7):419-23. PubMed ID: 2970777
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of the effects of enoximone by a dobutamine infusion.
Vincent JL; Madhoun P; Primo G; Kahn RJ
Intensive Care Med; 1989; 15(8):530-1. PubMed ID: 2532656
[TBL] [Abstract][Full Text] [Related]
10. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
Holubarsch C; Hasenfuss G; Thierfelder L; Heiss HW; Just H
Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation].
Birnbaum DE; Preuner JG; Gieseke R; Kasper-König W; Trenk D; Jähnchen E; Dieterich HA
Z Kardiol; 1991; 80 Suppl 4():47-52. PubMed ID: 1833897
[TBL] [Abstract][Full Text] [Related]
12. [Enoximone as an alternative to mechanical circulatory support prior to heart transplantation].
Schmid ER; Zollinger A; Turina M; Dieterich HA
Schweiz Med Wochenschr; 1989 Sep; 119(36):1231-6. PubMed ID: 2529633
[TBL] [Abstract][Full Text] [Related]
13. Intravenous use of enoximone.
Crawford MH
Am J Cardiol; 1987 Aug; 60(5):42C-45C. PubMed ID: 2956867
[TBL] [Abstract][Full Text] [Related]
14. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
Saborowski F; Peters P; Schneider M
Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the hemodynamic effects of dobutamine and enoximone in the treatment of low cardiac output after valvular surgery].
George M; Atallah G; Lehot JJ; Bastien O; Durand PG; Estanove S
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():57-62. PubMed ID: 2147836
[TBL] [Abstract][Full Text] [Related]
16. [Oral enoximone therapy as a therapeutic bridging before heart transplantation].
Zeplin HE; Stegmann T; Fell JJ; Dressler HT; Dieterich HA
Z Kardiol; 1990 Nov; 79(11):753-7. PubMed ID: 2148996
[TBL] [Abstract][Full Text] [Related]
17. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
[TBL] [Abstract][Full Text] [Related]
18. [Hemodynamic effects of the new phosphodiesterase inhibitor enoximone in heart surgery patients].
Boldt J; Kling D; Schuhmann E; Dapper F; Hempelmann G
Anaesthesist; 1989 May; 38(5):238-44. PubMed ID: 2525351
[TBL] [Abstract][Full Text] [Related]
19. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
Weber KT; Janicki JS; Jain MC
J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
[TBL] [Abstract][Full Text] [Related]
20. The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias.
Miles WM; Heger JJ; Minardo JD; Klein LS; Prystowsky EN; Zipes DP
Am Heart J; 1989 Jan; 117(1):112-21. PubMed ID: 2521415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
